At ATANIS Biotech AG, our mission is to revolutionize the way allergies are diagnosed and thereby to improve treatment success Our novel cell-based assay allows us to quantify patients allergic status with unparalleled diagnostic accuracy, without needing to expose patients to the culprit allergen.
Products, services, technology
We have established a method to mimic allergic reactions in a test tube, keeping potentially harmful allergens away from the patient during diagnosis. All we require for the diagnostic work up is a small sample of patient derived blood serum or plasma.
Cooperation possibilities
Our proprietary mast cell line functions as an ex vivo alternative to in vivo testing. Our assay is used as a biomarker for drug discovery and development, by big pharma and biotech companies. It is further used to assess allergenicity of foods, drugs and blood derived products.
